Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nuclease-resistant ribozymes decrease stromelysin mRNA levels in rabbit synovium following exogenous delivery to the

C M Flory1, P A Pavco, T C Jarvis

  • 1Department of Immunopathology, Parke-Davis Pharmaceutical Research, Division Warner-Lambert Company, Ann Arbor, MI 48105, USA.

Proceedings of the National Academy of Sciences of the United States of America
|January 23, 1996
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Further observations on the effect of benzene on a strain of myeloid chloroleukemia in mice and on changes produced in the leukemic cells by the chemical.

Blood·2010
Same author

Modifications of tuberculous lesions in patients treated with streptomycin.

The American journal of pathology·2010
Same author

A transparent chamber for the observation of the pancreas of the living mouse.

The Anatomical record·2010
Same author

Arterial Occlusions Produced by Emboli from Eroded Aortic Atheromatous Plaques.

The American journal of pathology·2009
Same author

Strategies for oligoribonucleotide synthesis according to the phosphoramidite method.

Current protocols in nucleic acid chemistry·2008
Same author

Weight bearing as a measure of disease progression and efficacy of anti-inflammatory compounds in a model of monosodium iodoacetate-induced osteoarthritis.

Osteoarthritis and cartilage·2003

Synthetic ribozymes effectively reduced stromelysin mRNA in a rabbit arthritis model, demonstrating potential for treating metalloproteinase-related inflammatory diseases.

Area of Science:

  • Molecular Biology
  • Gene Therapy
  • Rheumatology

Background:

  • Ribozymes (catalytic RNA) are explored for gene expression control.
  • In vivo efficacy of synthetic, stabilized ribozymes remains unproven.
  • Stromelysin, a matrix metalloproteinase, is implicated in arthritis pathogenesis.

Purpose of the Study:

  • To assess the in vivo localization, stability, and efficacy of antistromelysin ribozymes in a rabbit arthritis model.
  • To investigate the therapeutic potential of inhibiting stromelysin for arthritis treatment.

Main Methods:

  • Intraarticular administration of chemically modified hammerhead ribozymes targeting stromelysin mRNA in rabbits with interleukin 1-induced arthritis.
  • Evaluation of ribozyme uptake, stability in synovial tissue, and reduction of stromelysin mRNA levels.

Related Experiment Videos

  • Comparison with catalytically inactive ribozymes to confirm mechanism of action.

    • Main Results:

    • Ribozymes were successfully delivered and taken up by synovial lining cells.
    • The administered ribozymes demonstrated stability within the synovium.
    • A significant reduction in interleukin 1 alpha-induced stromelysin mRNA was observed.
    • Catalytically inactive ribozymes did not produce the same effect, supporting a cleavage-mediated mechanism.

    Conclusions:

    • Synthetic, stabilized ribozymes can be delivered in vivo to target specific mRNA.
    • Ribozyme treatment effectively reduced stromelysin mRNA in an arthritis model.
    • These findings support the therapeutic potential of ribozymes for metalloproteinase-related arthritic conditions.